Abstract
Evidence-based guidelines for the treatment of established fungal infections – invasive candidiasis – in adult haematology and ICU patients are presented. These guidelines updated those published in the Czech Republic in 2003/2004.
The quality of the clinical trials was assessed using the evidence criteria of the Infectious Diseases Society of America (IDSA) and the updated EORTC/MSG Consensus Group conclusions were used for definitions of invasive fungal disease.